Needham, MA, United States of America

Albert Thomas Profy

USPTO Granted Patents = 2 

Average Co-Inventor Count = 1.5

ph-index = 1


Company Filing History:


Years Active: 2013-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Albert Thomas Profy

Introduction

Albert Thomas Profy is an accomplished inventor based in Needham, MA (US). He holds two patents that focus on significant advancements in medical treatments. His work primarily addresses metabolic syndrome and papillomavirus infections, showcasing his commitment to improving health outcomes.

Latest Patents

Profy's latest patents include a method for treating metabolic syndrome using a stimulator of soluble guanylate cyclase (sGC). This invention provides a comprehensive approach to managing metabolic syndrome by combining sGC stimulation with various medications aimed at lowering blood glucose, blood pressure, and cholesterol levels. Additionally, he has developed a method for treating and preventing papillomavirus infections through the use of condensation polymers derived from aromatic sulfonic acids and aldehydes.

Career Highlights

Throughout his career, Profy has made significant contributions to the pharmaceutical industry. He has worked with notable companies such as Cyclerion Therapeutics, Inc. and Endo Pharmaceuticals Solutions Inc. His expertise in the field has led to innovative solutions that address critical health issues.

Collaborations

Profy has collaborated with esteemed colleagues, including John P. Hanrahan and James D. Wakefield. These partnerships have further enhanced his research and development efforts in the medical field.

Conclusion

Albert Thomas Profy is a notable inventor whose work has the potential to impact the treatment of metabolic syndrome and papillomavirus infections. His innovative patents and collaborations reflect his dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…